Entrepreneurial Spirit, Rooted in Tradition. At Mitsubishi Tanabe Pharma America, Inc. (MTPA), we can tout a storied reputation more than 300 years in the making. Our parent company, Mitsubishi Tanabe Pharma Corporation, is a research-driven pharmaceutical company with global reach – and one of Japan’s oldest and most respected companies.
With the recent FDA approval and availability in the U.S. of RADICAVA® (edaravone) MTPA is rapidly expanding our operation across all functional areas to launch this new product in the U.S. market. Concurrently, the company is expanding its research efforts and exploring collaborations with partners to discover and bring treatments to market for unmet medical needs including orphan diseases. We currently seek motivated professionals who share our vision of scientific excellence, innovation, and unwavering dedication to improving the lives of patients.
The Associate Director, Health Economics and Outcomes Research (HEOR) plays an integral role in supporting the Medical Affairs team. The incumbent will help refine MTPA’s HEOR strategy and tools, validate the HEOR cost impact model, and assist in design, development and implementation of various research projects (e.g., Real-world Evidence (RWE), Budget Impact Models, etc.). These studies will help shape the company’s health outcomes strategies and ultimately impact bottom line business performance. Responsibilities include identification of appropriate data sources, design and execution of stand-alone studies, compiling high-quality, well-written summaries and communicating findings to various audiences through formal presentations.